Healthcare-Associated Infections in Patients with COVID-19: Is It Different from the Pre-Pandemic Period
dc.contributor.author | Solmaz, İhsan | |
dc.contributor.author | Kavak, Şeyhmus | |
dc.contributor.author | Arac, Songul | |
dc.contributor.author | Akelma, Hakan | |
dc.contributor.author | Başgöz, Bahadir Bilgin | |
dc.contributor.author | Koyun, Sedrettin | |
dc.contributor.author | Kaya, Şafak | |
dc.date.accessioned | 2025-09-15T16:30:24Z | |
dc.date.available | 2025-09-15T16:30:24Z | |
dc.date.issued | 2024 | |
dc.description.abstract | Introduction: Healthcare-associated infections (HAIs) are common in intensive care unit (ICU) patients and may cause devastating consequences. However, the prevalence of HAI and its effects on in-hospital mortality among critically ill COVID-19 patients is ambiguous. We determined the prevalence of HAI and the rate of mortality in critically ill COVID-19 patients and compared it with pre-pandemic ICU patients. Methodology: This retrospective study was conducted with adult ICU patients admitted to Gazi Yasargil Training and Research Hospital (Diyarbakir,Turkey) in April-November 2019 (defined as the pre-pandemic period) and in April-November 2020 (defined as the pandemic period). All patients in the pandemic period had COVID-19, while none in the pre-pandemic period did. Patients diagnosed with HAIs during the in-hospital follow-up period were recorded. Results: Of 4596 enrollees, 3386 (73.7%) were pandemic-period patients and 1210 (26.3%) were pre-pandemic-period patients. HAI prevalence was significantly higher at 5.9% (n = 71) in the pandemic-period patients and 2.7% (n = 91) in the pre-pandemic-period patients (p < 0.001). Comorbidities including hypertension (63.4% vs 14.2%, p < 0.001), diabetes mellitus (39.4% vs 8.8%, p < 0.001), and coronary artery disease (30.9% vs 10.9%, p = 0.002) were significantly more frequent in pandemic-period HAI-positive patients. The most common HAI was catheter-related bloodstream infection in both groups, with similar frequency (p = 0.652). In-hospital mortality rate was 85.9% versus 65.9% in pandemic- versus pre-pandemic-period HAI-positive patients (p < 0,05). Conclusions: The prevalence of HAI and the in-hospital mortality rate was significantly higher among pandemic-period patients. © 2024 Elsevier B.V., All rights reserved. | en_US |
dc.identifier.doi | 10.3855/jidc.19548 | |
dc.identifier.issn | 1972-2680 | |
dc.identifier.issn | 2036-6590 | |
dc.identifier.scopus | 2-s2.0-85208602684 | |
dc.identifier.uri | https://doi.org/10.3855/jidc.19548 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12514/9299 | |
dc.language.iso | en | en_US |
dc.publisher | Journal of Infection in Developing Countries | en_US |
dc.relation.ispartof | Journal of Infection in Developing Countries | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Healthcare-Associated Infections | en_US |
dc.subject | Intensive Care Units | en_US |
dc.subject | C Reactive Protein | en_US |
dc.subject | Lactate Dehydrogenase | en_US |
dc.subject | Lactate Dehydrogenase A | en_US |
dc.subject | Procalcitonin | en_US |
dc.subject | SPSS 24 | en_US |
dc.subject | C Reactive Protein | en_US |
dc.subject | Lactate Dehydrogenase | en_US |
dc.subject | Procalcitonin | en_US |
dc.subject | Acinetobacter baumannii | en_US |
dc.subject | Adult | en_US |
dc.subject | Aged | en_US |
dc.subject | Article | en_US |
dc.subject | Bloodstream Infection | en_US |
dc.subject | Chronic Kidney Failure | en_US |
dc.subject | Chronic Obstructive Lung Disease | en_US |
dc.subject | Coronary Artery Disease | en_US |
dc.subject | Coronavirus Disease 2019 | en_US |
dc.subject | Critically Ill Patient | en_US |
dc.subject | Diabetes Mellitus | en_US |
dc.subject | Escherichia coli | en_US |
dc.subject | Female | en_US |
dc.subject | Healthcare Associated Infection | en_US |
dc.subject | Hospitalization | en_US |
dc.subject | Human | en_US |
dc.subject | Hypertension | en_US |
dc.subject | Intensive Care Unit | en_US |
dc.subject | Klebsiella pneumoniae | en_US |
dc.subject | Length of Stay | en_US |
dc.subject | Major Clinical Study | en_US |
dc.subject | Male | en_US |
dc.subject | Middle Aged | en_US |
dc.subject | Morganella morganii | en_US |
dc.subject | Mortality | en_US |
dc.subject | Pandemic | en_US |
dc.subject | Polymerase Chain Reaction | en_US |
dc.subject | Prevalence | en_US |
dc.subject | Retrospective Study | en_US |
dc.subject | Staphylococcus aureus | en_US |
dc.subject | Urinalysis | en_US |
dc.subject | Urinary Tract Infection | en_US |
dc.subject | Ventilator Associated Pneumonia | en_US |
dc.subject | Comorbidity | en_US |
dc.subject | Complication | en_US |
dc.subject | Critical Illness | en_US |
dc.subject | Cross Infection | en_US |
dc.subject | Epidemiology | en_US |
dc.subject | Hospital Mortality | en_US |
dc.subject | Severe Acute Respiratory Syndrome Coronavirus 2 | en_US |
dc.subject | Turkey (Bird) | en_US |
dc.subject | Adult | en_US |
dc.subject | Aged | en_US |
dc.subject | Comorbidity | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Critical Illness | en_US |
dc.subject | Cross Infection | en_US |
dc.subject | Female | en_US |
dc.subject | Hospital Mortality | en_US |
dc.subject | Humans | en_US |
dc.subject | Intensive Care Units | en_US |
dc.subject | Male | en_US |
dc.subject | Middle Aged | en_US |
dc.subject | Prevalence | en_US |
dc.subject | Retrospective Studies | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | Turkey | en_US |
dc.title | Healthcare-Associated Infections in Patients with COVID-19: Is It Different from the Pre-Pandemic Period | |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
gdc.author.scopusid | 57190736838 | |
gdc.author.scopusid | 55343958400 | |
gdc.author.scopusid | 57218626712 | |
gdc.author.scopusid | 56369321000 | |
gdc.author.scopusid | 56392980100 | |
gdc.author.scopusid | 59403533600 | |
gdc.author.scopusid | 59403533600 | |
gdc.description.department | Artuklu University | en_US |
gdc.description.departmenttemp | [Solmaz] İhsan, Department of Internal Medicine, University of Health Sciences, Istanbul, Turkey; [Kavak] Şeyhmus, Department of Radiology, University of Health Sciences, Istanbul, Turkey; [Arac] Songul, Accident and Emergency Department, University of Health Sciences, Istanbul, Turkey; [Akelma] Hakan, Department of Anesthesiology, University of Artuklu, Mardin, Turkey; [Başgöz] Bahadir Bilgin, Department of Internal Medicine, University of Health Sciences, Istanbul, Turkey; [Koyun] Sedrettin, Department of Internal Medicine, Kızıltepe State Hospital, Mardin, Turkey; [Kaya] Şafak, Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Istanbul, Turkey | en_US |
gdc.description.endpage | S72 | en_US |
gdc.description.issue | 9 | en_US |
gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
gdc.description.scopusquality | Q3 | |
gdc.description.startpage | S67 | en_US |
gdc.description.volume | 18 | en_US |
gdc.description.wosquality | Q4 | |
gdc.identifier.pmid | 39499749 |